During the Symposium

Poster presenters will be available during the below hours for live Q&A.

Before and After the Symposium

We have asked that poster presenters make themselves available online, in the iPoster system during the following days and hours.

December 5 & 6

6:00 AM – 7:00 AM EST USA

11:20 AM – 1:00 PM EST USA

Poster Session #1 – Dec. 5, 9:20 – 9:40 AM

  • Kristen Bibeau, PhD, MSPH

    Quality of Life in Patients With Vitiligo: Results From a Patient Survey Conducted in Europe, Japan, and the United States

  • Marwa Safwat EL-Hawary, MD

    Metabolic Syndrome in Early Onset versus Late Onset Vitiligo

  • Ju Hee Han, MD

    Mass Screening on Comorbidities of Vitiligo: A Nationwide Population-based Study

  • Solam Lee, MD

    An Identification of Potential Therapeutics for Vitiligo by Mass Screening for 1,732 Medicines in Korean National Health Insurance Database

  • Vidhya Shankar Narayan, MD
    1. Patients’ Perspective on Current Treatments and Demand for Novel Treatments for Vitiligo
    2. What is a successful repigmentation in vitiligo from patients’ view?
  • Mauro Picardo MD

    Vitiligo: Possible Contribution of Keratinocytes

  • Nanis Ragab, MD

    Support for increased cardiovascular risk in non-segmental vitiligo among Egyptians: A hospital-based, case-control study.

Poster Session #2 – Dec. 5, 10:50 – 11:10 AM

  • Fabiana Castro Porto Silva Lopes, MD

    Assessing Delays in the Treatment of Vitiligo

  • Ajay Jaywant Deshpande, MBBS, DVD, DNB

    308 Excimer Lamp for Mucosal Vitiligo

  • Kavita Gandhi, BS.Pharm, MS

    A Qualitative Interview Study Exploring the Impacts of Vitiligo Among Adults and Adolescents

  • Neha Karthik, MBBS

    Vitiligo and Cochlear Damage

  • Aparna Krishnappa, MD

    Therapeutic Effect of Oral Vitamin B12, Folic Acid Supplements With Narrow Band UVB (Triple Therapy) in Vitiligo Vulgaris Patients

Poster Session #3 – Dec. 6, 9:20 – 9:40 AM

  • Marwa Abdallah, MD

    E-Cadherin Expression in Different Anatomical Areas in Vitiligo Patients and Healthy Controls and Its Relation to Oxidative Stress

  • Jung Min Bae, MD, PhD

    Non-Cultured Melanocyte-Keratinocyte Transplantation Using Suction Blisters to Treat Refractory Vitiligo: A Retrospective Study of 41 Cases in Korea

  • Deepti Hemendra Ghia, MD

    Success of Combination of Cellular and Tissue Grafting Techniques in Previously Operated Areas With Partially Re-Pigmented Patches of Vitiligo

  • Hyun Jeong Ju, MD

    Differential Diagnosis of Childhood Hypopigmentation: A Retrospective Study of 1,783 Patients

  • Nilesh N. Goyal, MRCP UK, DNB, DVD, SCS Dip

    Follicular Unit Extraction Hair Transplant Into Stable Vitiligo on Glabrous Skin With a Surgical Twist

  • Rania Mohamed Mogawer, PhD

    Serum Leptin in Segmental and Non-Segmental Vitiligo: A Comparative Controlled Study

Poster Session #4 – Dec. 6, 10:50 – 11:10 AM

  • Anup Kumar Bhattacharya, MD

    A Study of Various Trace Elements in Vitiligo

  • Solwan I. El-Samanoudy, MD

    Why Is the Pigment Retained Perifollicularly in Systemic Sclerosis Associated Depigmentation?: Histological and Immunohistochemical Study

  • Manisha Mareddy, MBBS
    1. Needling With 5 Fluorouracil Cream as a Treatment of Vitiligo
    2. Assessing Disease Stability in Vitiligo Using Dermoscopy
    3. Serum Vitamin D and Homocysteine Levels in Vitiligo Receiving NBUVB Phototherapy
  • Ahmed Mahmoud Mohamed Nassar, MSc

    Recurrence of Segmental Vitiligo After Non-Cultured Cellular Grafting

  • Botir Saatov, PhD, DSc.

    Development and Implementation of the External Drug “Lipovitilin” in the Treatment of Vitiligo Using Nanotechnology

  • Iman Sany, MD

    Evaluation of Phosphodiesterase 4 Enzyme Level in Lesional Skin and Serum of Vitiligo Patients